Dr. Georgeta-Polixenia Iorga – Medic Primar

Dr. Georgeta-Polixenia Iorga - Medic Primar

Specialitatea - Oncologie

Experienta Profesionala

  • Perioada: 01/06/2002-31/10/2006 Medic specialist oncologie la Spitalul Clinic Coltea, Bucuresti (Romania)
  • Perioada: 01/11/2006-Prezent Medic primar oncologie Spitalul Universitar de Urgenta, Bucuresti (Romania)

Educatie si formare

  • 01/09/1990–30/06/1996 Licenta medic UMF Gr.T.Popa-Facultatea de Medicina, Iasi (România)
  • 01/04/1997–30/03/2002 Rezidentiat oncologie medicala Institutul Oncologic, Bucuresti (România) – Medic specialist oncologie-Ord. MS 256/2002 – Medic primar oncologie-Ord. MS 1971/2008

Competenţe dobandite la locul de munca

  • Subinvestigator in 12 studii clinice randomizate de faza III(cancer pulmonar,cancer mamar,cancer ovarian,cancer pancreatic)din 2002
  • Investigator principal in- 11 studii clinice randomizate de faza III(cancer pulmonar,cancer mamar,cancer colorectal)
  • 2 studii clinice de faza IV cancer pulmonar ,1 studiu faza IV cancer ovarian

Publicatii

  • “Round table: Problems and therapeutic solutions in the management of locally-advanced non-small cell lung cancer”- coauthor, Romanian Congress of Oncology, mai, 2003”
  • “A comparative evaluation of surgery followed by adjuvant chemo-radiation versus neoadjuvant chemotherapy followed by concurrent chemo-radiation, for stage IIIA non-small cell lung cancer (NSCLC). A multi-institutional study.”- coauthor, Published in Romanian Oncological Journal 2003
  • “Adjuvant chemotherapy (CT) for completely resected non-small cell lung cancer(NSCLC). A retrospective analysis of 311 patients”- coauthor, accepted for presentation at The International Congress on anticancerTreatment, 9-12 February, 2004, Paris, France, published in Lung Cancer (jan 2005) 47, 93-101
  • “Topotecan(T) and fractionated Cisplatin (CDDP) as first line chemotherapy for extensive small cell lung cancer (E-SCLC): a phase I/II study”(2096)- coauthor ASCO 2000 Abstract on CD-ROM
  • “Split course radiation with concurent navelbine and cisplatin in locally advanced non-small lung cancer” a phase II multi-institutional study, published in Journal of BUON 9:167-172, 2004- coauthor 2006: Mircea Dediu; Aurelia Alexandru; Dragos Median; R Anghel; Alin Tarlea; Polixenia Iorga; M Movanu
  • Compliance with adjuvant chemotherapy in non-small cell lung cancer. The experience of a single institution evaluating a cohort of 356 patients. Journal of B.U.ON: official journal of the Balkan Union of Oncology 2006;11(4):425-32.
  • “COPD prevalence in lung cancer patients- Is COPD a risk factor in lung cancer?” By Doina Tofolean, Laura Mazilu, Tatiana Adam, Andra-Iulia Suceveanu, Polixenia Iorga, and Ioan Tiberiu Tofolean Article | Published in 2011 in European Respiratory Journal 38 (Suppl 55)
  • “A comparative evaluation of surgery followed by adjuvant chemo-radiation versus neoadjuvant chemotherapy followed by concurrent chemo-radiation, for stage III A non-small cell lung cancer (NSCLC)” A multi-institutional study. Citation: Annals of Oncology, Vol 11, Suppl 4 October 2000, page 121.